Effective Pharmacological Treatment of Painful Diabetic Neuropathy by Nurse Practitioners: Results of an Algorithm-based Experience
Overview
Neurology
Psychiatry
Authors
Affiliations
Objective: To improve the care of patients with painful diabetic polyneuropathy (PDP) by a specialized outpatient clinic for individuals referred by general practitioners and to determine the effects on pain, quality of life, and patient satisfaction.
Material And Methods: One hundred twenty-one patients were prospectively enrolled. At baseline and after 12 months at end of treatment, patients filled in a set of validated questionnaires on severity and interference of pain, quality of life, anxiety and depression, and patient satisfaction with the service offered.
Setting: The outpatient clinic is part of a regional chronic care management program, which includes both hospital-based endocrinologists and general practitioners.
Results: Twenty-eight patients (27%) did not need any further treatment after one visit to the outpatient clinic. As initial drug, pregabalin was the most commonly prescribed drug (65%); amitriptyline was prescribed in only 30% due to its contraindications. Improvements were found in all pain scores (P < 0.05). Pain interference was improved in sleep (P < 0.01), general activity, and mood (P < 0.05). More than half of the patients (65%) were satisfied with the treatment and wished no further medication changes; 52% had a treatment success defined as pain relief ≥ 30%. Medication was stopped due to inefficacy in 9% of patients and changed due to adverse effects in 20% of the patients.
Conclusions: A specialized outpatient clinic for patients with PDP is an effective health care service. Using diagnostic instruments and a defined treatment algorithm, significant pain reduction was achieved in the majority of patients in a relative short period of time.
Geerts M, Hoeijmakers J, Essers B, Merkies I, Faber C, Goossens M PLoS One. 2024; 19(4):e0298881.
PMID: 38626240 PMC: 11020963. DOI: 10.1371/journal.pone.0298881.
van Laake-Geelen C, Smeets R, Goossens M, Verbunt J J Rehabil Med Clin Commun. 2021; 4:1000046.
PMID: 33884148 PMC: 8054751. DOI: 10.2340/20030711-1000046.
van Laake-Geelen C, Smeets R, van Meulenbroek T, den Hollander M, Goossens M, Verbunt J J Rehabil Med Clin Commun. 2021; 2:1000015.
PMID: 33884116 PMC: 8008735. DOI: 10.2340/20030711-1000015.
Pathways in the diagnosis and management of diabetic polyneuropathy.
Kaku M, Vinik A, Simpson D Curr Diab Rep. 2015; 15(6):609.
PMID: 25899758 PMC: 4440893. DOI: 10.1007/s11892-015-0609-2.